Then, the cellular components (Figure 1B and Figure S1B) as well as the spatial localisation of IRF5 (Figure 1C and Figure S1C) were calculated after spatial transcriptomics deconvolution, and it was found that IRF5 was mainly localised to tumour cells, DC cells and B cells. This evidence concerns the gene IRF5 and neoplasm.